Inspire Medical Systems, based in Minneapolis, Minnesota, is the world's leading developer of innovative, implantable neurostimulation technologies to treat Obstructive Sleep Apnea (OSA). Utilizing well-established technologies from the fields of cardiac pacing and neurostimulation, Inspire has developed a proprietary Upper Airway Stimulation (UAS) therapy for patients who suffer from OSA. Inspire was formed in 2007 when the technology and a significant intellectual property portfolio was spun-out of Medtronic (NYSE: MDT).
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 05/11/12 | $14,500,000 | Series B |
Medtronic U.S. Venture Partners | undisclosed |
| 05/15/14 | $40,000,000 | Series E |
Aperture Venture Partners Johnson & Johnson Innovation Medtronic OrbiMed Advisors US Venture Partners | undisclosed |
